Quintet Private Bank Europe S.A. Has $26.03 Million Stake in Intuitive Surgical, Inc. $ISRG

Quintet Private Bank Europe S.A. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,206 shares of the medical equipment provider’s stock after purchasing an additional 4,609 shares during the period. Intuitive Surgical comprises about 1.5% of Quintet Private Bank Europe S.A.’s portfolio, making the stock its 21st largest holding. Quintet Private Bank Europe S.A.’s holdings in Intuitive Surgical were worth $26,031,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Tobam grew its holdings in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC bought a new stake in Intuitive Surgical during the second quarter worth about $27,000. TD Capital Management LLC boosted its position in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC bought a new position in Intuitive Surgical in the first quarter valued at approximately $30,000. Finally, Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In related news, Director Craig H. Barratt sold 750 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 464 shares of the company’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the transaction, the senior vice president directly owned 443 shares in the company, valued at approximately $242,981.07. This represents a 51.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 114,007 shares of company stock valued at $63,533,844. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $554.58 on Wednesday. The firm has a market capitalization of $198.81 billion, a PE ratio of 73.36, a PEG ratio of 5.14 and a beta of 1.68. The company’s 50-day moving average is $534.09 and its 200-day moving average is $505.41. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the previous year, the firm posted $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently commented on ISRG. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday. The Goldman Sachs Group upped their price target on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 24th. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Finally, Daiwa Capital Markets raised their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $608.79.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.